Gain Therapeutics Stock Forecast

Sell candidate since Jun 22, 2026

The Gain Therapeutics, Inc. stock price fell by -1.60% on the last day (Monday, 22nd Jun 2026) from $1.88 to $1.85. During the last trading day the stock fluctuated 5.85% from a day low at $1.84 to a day high of $1.95. The price has fallen in 6 of the last 10 days but is still up by 8.82% over the past 2 weeks. Volume has increased on the last day by 293 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 791 thousand shares were bought and sold for approximately $1.46 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.80% during the next 3 months and, with a 90% probability hold a price between $1.39 and $1.82 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

GANX Signals & Forecast

The Gain Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.77 and $1.79. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 18, 2026, and so far it has fallen -1.60%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Gain Therapeutics, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Gain Therapeutics, Inc. stock

Gain Therapeutics, Inc. finds support from accumulated volume at $1.82 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.108 between high and low, or 5.85%. For the last week, the stock has had daily average volatility of 5.42%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GANX) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Gain Therapeutics, Inc. to open at $1.88, and during the day (based on 14 day Average True Range), to move between $1.79 and $1.91, which gives a possible trading interval of +/-$0.119 (+/-6.64%) up or down from last closing price. If Gain Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 6.64% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.82 (1.62%) than the resistance at $1.89 (2.16%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Gain Therapeutics, Inc. stock A Buy?

Gain Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -1.078 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $1.88 ( 1.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk